A potent antibiotic named for its vivid purple color and soil-dwelling origins
In short: Discovered in 1963, gentamicin is a powerful antibiotic derived from the bacterium Micromonospora purpurea. While it remains a critical tool for treating severe infections like sepsis, its unique chemical structure and complex production process continue to challenge researchers aiming to optimize its therapeutic potential and minimize its significant side effects.
Gentamicin was discovered in 1963 by researchers at the Schering Corporation, including Weinstein and Wagman, who isolated it from soil samples. The bacterium responsible for its production, Micromonospora purpurea, grows in a vivid purple hue reminiscent of the dye Gentian Violet, which inspired the antibiotic's name. Unlike many other antibiotics that end in 'mycin'—a suffix reserved for those produced by the genus Streptomyces—gentamicin and its relatives end in 'micin' to reflect their distinct biological origins within the Micromonospora genus.
The drug functions by binding to the 30S subunit of bacterial ribosomes, effectively sabotaging protein synthesis. By forcing the ribosome to accept incorrect amino acids, it causes the production of non-functional, misfolded proteins that lead to bacterial death. Furthermore, it can create a pool of inactive ribosomes by interfering with the recycling process. Despite this efficacy, gentamicin is notoriously nephrotoxic and ototoxic, with kidney damage occurring in 10–25% of patients and inner ear damage affecting about 11% of those treated. These risks are often dose-related and can have delayed presentations.
The production of gentamicin is a complex, ongoing challenge. It is synthesized through submerged fermentation, and the resulting mixture is a variable cocktail of components, with the gentamicin C complex—comprising C1, C1a, and C2—accounting for about 80% of the mixture and providing the highest antibacterial activity. Because the antibiotic is collected at the cell surface, researchers are currently investigating the biosynthesis pathway to identify genes that could be re-engineered to force the bacteria to secrete the drug, potentially increasing yields. Today, it remains a World Health Organization essential medicine, though its use requires careful monitoring due to its potential for permanent hearing loss and kidney dysfunction.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Gentamicin
To cite this card, link to https://intellectplus.co.uk/app/nature-gentamicin.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Organisms · More in Nature · Latest · A–Z · All topics
